MTHFD1 Regulates Autophagy to Promote Growth and Metastasis in Colorectal Cancer via the PI3K-AKT-mTOR Signaling Pathway
- PMID: 39571599
- PMCID: PMC11581708
- DOI: 10.1002/cam4.70267
MTHFD1 Regulates Autophagy to Promote Growth and Metastasis in Colorectal Cancer via the PI3K-AKT-mTOR Signaling Pathway
Abstract
Objectives: Methylenetetrahydrofolate dehydrogenase 1 (MTHFD1) is the enzyme with the activities of methylenetetrahydrofolate dehydrogenase, methylenetetrahydrofolate cyclohydrolase, and formyltetrahydrofolate synthetase. Our aim was to elucidate the function of MTHFD1 in colorectal cancer (CRC).
Methods: In vitro assessments of the proliferation, invasion, and migration abilities of CRC cells were conducted using Immunohistochemistry, Transwell invasion assays, Western blot (WB), and Cell counting Kit-8 assays. WB was also utilized to measure autophagy protein levels and PI3K-AKT-mTOR signaling pathway expression. Furthermore, the role of MTHFD1 was evaluated in vivo by using subcutaneous xenograft tumor models and lateral tail vein metastasis models of human CRC in nude mice.
Results: Overexpression of MTHFD1 promoted the abilities of tumorigenesis and metastasis in CRC in vitro and in vivo and reduced autophagy, attributing to the PI3K-AKT-mTOR signaling pathway in CRC cells. In contrast, the down-regulation of MTHFD1 increased autophagy and suppressed their proliferation, migration, and invasion.
Conclusions: MTHFD1 can modulate the PI3K-AKT-mTOR signaling pathway to suppress autophagy and stimulate tumorigenesis and metastasis.
Keywords: MTHFD1; PI3K‐AKT‐mTOR; autophagy; colorectal cancer; invasion; migration; proliferation.
© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures





References
-
- Ciardiello F., Ciardiello D., Martini G., Napolitano S., Tabernero J., and Cervantes A., “Clinical Management of Metastatic Colorectal Cancer in the Era of Precision Medicine,” CA: A Cancer Journal for Clinicians 72, no. 4 (2022): 372–401. - PubMed
-
- Arnold M., Sierra M. S., Laversanne M., Soerjomataram I., Jemal A., and Bray F., “Global Patterns and Trends in Colorectal Cancer Incidence and Mortality,” Gut 66, no. 4 (2017): 683–691. - PubMed
-
- Dekker E., Tanis P. J., Vleugels J. L. A., Kasi P. M., and Wallace M. B., “Colorectal Cancer,” Lancet 394, no. 10207 (2019): 1467–1480. - PubMed
-
- Kamynina E., Lachenauer E. R., DiRisio A. C., Liebenthal R. P., Field M. S., and Stover P. J., “Arsenic Trioxide Targets MTHFD1 and SUMO‐Dependent Nuclear De Novo Thymidylate Biosynthesis,” Proceedings of the National Academy of Sciences of the United States of America 114, no. 12 (2017): E2319–E2326. - PMC - PubMed
MeSH terms
Substances
Grants and funding
- SL2024B03J00078/Key Research and Development Program of Guangzhou City
- 23xkjc023/Fundamental Research Funds for the Central Universities, Sun Yat-sen University
- 2022YFA1304000/National Key Research and Development Program of China
- 82370675/the National Natural Science Foundation of China
- 81970452/the National Natural Science Foundation of China
- U21A20344/National Natural Science Foundation of China Key Joint Project
- 2020B1111170004/the program of the Guangdong Provincial Clinical Research Center for Digestive Diseases
- 2020B1212070028/open project of Guangdong Provincial Key Laboratory of Human Disease Genomics
- BGIRSZ20220008/open project of BGI-Shenzhen, Shenzhen 518000, China
- JCYJ20190807161807867/Science and Technology Program of Shenzhen, China
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous